Stay updated on Benralizumab in Hypereosinophilic Syndrome Clinical Trial

Sign up to get notified when there's something new on the Benralizumab in Hypereosinophilic Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Benralizumab in Hypereosinophilic Syndrome Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Locations section was added with Maryland as a location, and the page revision was updated to v3.3.3. The Maryland Locations subsection and the HHS Vulnerability Disclosure link were removed, and the previous revision v3.3.2 was deleted.
    Difference
    0.2%
    Check dated 2025-12-24T19:49:37.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Publication notes were updated to indicate that PubMed automatically fills the list; the revision tag changed from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T14:46:44.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Notice about lapse in government funding and related operating status details was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:29:58.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Both screenshots preserve the core study information (overview, eligibility criteria, primary and secondary outcomes, locations) with only minor formatting/layout differences. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T21:13:00.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Page content updated to v3.2.0, add new resource Eosinophilic gastroenteritis, include government operating status notice; removed reference to v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T08:55:08.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    - Removed several drug-safety/quality topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs). - Added a new version label: Revision: v3.1.0. - Also retain the new version tag without adding new substantive content beyond the label.
    Difference
    0.3%
    Check dated 2025-09-29T07:30:47.000Z thumbnail image

Stay in the know with updates to Benralizumab in Hypereosinophilic Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Benralizumab in Hypereosinophilic Syndrome Clinical Trial page.